Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scott

Showing results (181-190 of 355) with videos related to

Pageof 36
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOPNorbert Schmitz, Samira Zeynalova, Maike Nickelsen, et al.
Nature Communications|January 17, 2018
AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesisMatt Teater, Pilar M Dominguez, David Redmond, et al.
Haematologica|March 5, 2026
Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVDJiayu Yang, Diego Villa, Alina S Gerrie, et al.
Biomedical Materials (Bristol, England)|December 7, 2019
Fast dissolving glucose porogens for early calcium phosphate cement degradation and bone regenerationEline-Claire Grosfeld, Brandon T Smith, Marco Santoro, et al.
Ejhaem|July 18, 2022
The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphomaKathrine T Isaksen, Klaus Beiske, Erlend B Smeland, et al.
Cancer Immunology Research|November 21, 2025
Phenotypic characterization and prognostic impact of CD103+ tissue-resident memory T cells in diffuse large B cell lymphomaGillian Savage, Katy Milne, Brett Collinge, et al.
Leukemia & Lymphoma|January 17, 2020
Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and <i>BCL2</i> gene alterationsLina Chen, Kathrin Tyryshkin, Alison Moore, et al.
British Journal of Haematology|October 22, 2016
Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experienceGreg Hapgood, Tom Pickles, Laurie H Sehn, et al.
The Journal of Molecular Diagnostics : JMD|February 26, 2021
Validation of the Double-Hit Gene Expression Signature (DLBCL90) in an Independent Cohort of Patients with Diffuse Large B-Cell Lymphoma of Germinal Center OriginHa Nguyen, Anamarija Perry, Pamela Skrabek, et al.
Blood Advances|December 6, 2019
Molecular features of a large cohort of primary central nervous system lymphoma using tissue microarrayDiego Villa, King L Tan, Christian Steidl, et al.
Pageof 36

Showing results (181-190 of 355) with videos related to

Sort By:
Pageof 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOPNorbert Schmitz, Samira Zeynalova, Maike Nickelsen, et al.
Nature Communications|January 17, 2018
AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesisMatt Teater, Pilar M Dominguez, David Redmond, et al.
Haematologica|March 5, 2026
Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVDJiayu Yang, Diego Villa, Alina S Gerrie, et al.
Biomedical Materials (Bristol, England)|December 7, 2019
Fast dissolving glucose porogens for early calcium phosphate cement degradation and bone regenerationEline-Claire Grosfeld, Brandon T Smith, Marco Santoro, et al.
Ejhaem|July 18, 2022
The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphomaKathrine T Isaksen, Klaus Beiske, Erlend B Smeland, et al.
Cancer Immunology Research|November 21, 2025
Phenotypic characterization and prognostic impact of CD103+ tissue-resident memory T cells in diffuse large B cell lymphomaGillian Savage, Katy Milne, Brett Collinge, et al.
Leukemia & Lymphoma|January 17, 2020
Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and <i>BCL2</i> gene alterationsLina Chen, Kathrin Tyryshkin, Alison Moore, et al.
British Journal of Haematology|October 22, 2016
Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experienceGreg Hapgood, Tom Pickles, Laurie H Sehn, et al.
The Journal of Molecular Diagnostics : JMD|February 26, 2021
Validation of the Double-Hit Gene Expression Signature (DLBCL90) in an Independent Cohort of Patients with Diffuse Large B-Cell Lymphoma of Germinal Center OriginHa Nguyen, Anamarija Perry, Pamela Skrabek, et al.
Blood Advances|December 6, 2019
Molecular features of a large cohort of primary central nervous system lymphoma using tissue microarrayDiego Villa, King L Tan, Christian Steidl, et al.
Pageof 36